DCBLD1 Modulates Angiogenesis by Regulation of the VEGFR-2 Endocytosis in Endothelial Cells
- 1 February 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 45 (2) , 198-217
Abstract
BACKGROUND: Unwanted angiogenesis is involved in the progression of various malignant tumors and cardiovascular diseases, and the factors that regulate angiogenesis are potential therapeutic targets. We tested the hypothesis that DCBLD1 (discoidin, CUB, and LCCL domain-containing protein 1) is a coreceptor of VEGFR-2 (vascular endothelial growth factor receptor-2) and modulates angiogenesis in endothelial cells. METHODS: A carotid artery ligation model and retinal angiogenesis assay were used to study angiogenesis using globe knockout or endothelial cell–specific conditional Dcbld1 knockout mice in vivo. Immunoblotting, immunofluorescence staining, plasma membrane subfraction isolation, Coimmunoprecipitation, and mass spectrum assay were performed to clarify the molecular mechanisms. RESULTS: Loss of Dcbld1 impaired VEGF (vascular endothelial growth factor) response and inhibited VEGF-induced endothelial cell proliferation and migration. Dcbld1 deletion interfered with adult and developmental angiogenesis. Mechanistically, DCBLD1 bound to VEGFR-2 and regulated the formation of VEGFR-2 complex with negative regulators: protein tyrosine phosphatases, E3 ubiquitin ligases (neuronal precursor cell-expressed developmentally downregulated gene 4, Nedd4 and c-Casitas B-lineage lymphoma, c-Cbl), and also Dcbld1 knockdown promoted lysosome-mediated VEGFR-2 degradation in endothelial cells. CONCLUSION: These findings demonstrated the essential role of endothelial DCBLD1 in regulating VEGF signaling and provided evidence that DCBLD1 promotes VEGF-induced angiogenesis by limiting the dephosphorylation, ubiquitination, and lysosome degradation after VEGFR-2 endocytosis. We proposed that endothelial DCBLD1 is a potential therapeutic target for ischemic cardiovascular diseases by the modulation of angiogenesis through regulation of the VEGFR-2 endocytosis.Keywords
This publication has 55 references indexed in Scilit:
- Predicting Secretory Proteins with SignalP2017
- NRP1 Presented in trans to the Endothelium Arrests VEGFR2 Endocytosis, Preventing Angiogenic Signaling and Tumor InitiationDevelopmental Cell, 2014
- The Neuropilin 1 Cytoplasmic Domain Is Required for VEGF-A-Dependent ArteriogenesisDevelopmental Cell, 2013
- Regulation of VEGF signaling by membrane trafficCellular Signalling, 2012
- Deregulation of Rab5 and Rab4 proteins in p85R274A-expressing cells alters PDGFR traffickingCellular Signalling, 2010
- VEGF Receptor 2 Endocytic Trafficking Regulates Arterial MorphogenesisDevelopmental Cell, 2010
- Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesisAngiogenesis, 2008
- Caveolin-Stabilized Membrane Domains as Multifunctional Transport and Sorting Devices in Endocytic Membrane TrafficCell, 2004
- Role of the endothelium in modulating neointimal formationJACC, 2004
- Structural and Functional Relation of Neuropilins2002